OUTLOOK THERAPEUTICS
OTLK Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-02-04
2025-02-06
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
12,323
$0.00
1
$56.39M
2024-10-03
2024-10-03
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
19,771
$0.00
1
$56.39M
2024-10-03
2024-10-03
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
19,771
$0.00
1
$56.39M
2024-09-26
2024-09-30
KENYON LAWRENCE
Chief Financial Officer
P - Purchase
Common Stock
5,000
$6.00
30,000
1
$56.39M
2024-03-20
2024-03-22
EVANSON JEFF
CHIEF COMMERCIAL OFFICER
A - Grant
Stock Option (Right to Buy)
25,000
$0.00
1
$56.39M
2024-03-20
2024-03-22
KENYON LAWRENCE
CHIEF FINANCIAL OFFICER
A - Grant
Stock Option (Right to Buy)
12,500
$0.00
1
$56.39M
2024-03-20
2024-03-22
TRENARY RUSSELL III
CEO AND PRESIDENT
A - Grant
Stock Option (Right to Buy)
455K
$0.00
1
$56.39M
2024-03-07
2024-03-11
EVANSON JEFF
CHIEF COMMERCIAL OFFICER
P - Purchase
Common Stock
62,484
$0.00
1
$56.39M
2024-03-07
2024-03-08
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
94,441
$0.00
1
$56.39M
2024-03-07
2024-03-08
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
94,441
$0.00
1
$56.39M
2023-04-20
2023-04-21
DAGNON TERRY
Chief Operations Officer
S - Sale
Common Stock
-520K
$1.00
-520K
1
$56.39M
2023-04-17
2023-04-19
EVANSON JEFF
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
192K
$0.00
1
$56.39M
2023-04-17
2023-04-19
DAGNON TERRY
Chief Operations Officer
A - Grant
Stock Option (Right to Buy)
192K
$0.00
1
$56.39M
2023-04-17
2023-04-19
TRENARY RUSSELL III
CEO and President
A - Grant
Stock Option (Right to Buy)
257K
$0.00
1
$56.39M
2023-03-29
2023-03-31
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
41,065
$0.00
1
$56.39M
2023-03-29
2023-03-31
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
41,065
$0.00
1
$56.39M
2023-01-20
2023-01-24
EVANSON JEFF
Chief Commercial Officer
S - Sale
Common Stock
-267K
$1.00
-267K
1
$56.39M
2023-01-19
2023-01-19
EVANSON JEFF
Chief Commercial Officer
S - Sale
Common Stock
-103K
$1.00
-103K
1
$56.39M
2023-01-18
2023-01-19
EVANSON JEFF
Chief Commercial Officer
S - Sale
Common Stock
-33,738
$1.00
-33,738
1
$56.39M
2023-01-17
2023-01-19
EVANSON JEFF
Chief Commercial Officer
S - Sale
Common Stock
-27,162
$1.00
-27,162
1
$56.39M
2022-10-05
2022-10-07
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
71,998
$0.00
1
$56.39M
2022-10-05
2022-10-07
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
74,878
$0.00
1
$56.39M
2022-06-21
2022-06-23
DAGNON TERRY
Chief Operating Officer
P - Purchase
Common Stock
10,000
$1.00
10,000
1
$56.39M
2022-06-21
2022-06-23
TRENARY RUSSELL III
CEO and President
P - Purchase
Common Stock
19,925
$1.00
19,925
1
$56.39M
2022-03-31
2022-04-04
DAGNON TERRY
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$56.39M
2022-03-31
2022-04-04
EVANSON JEFF
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$56.39M
2022-03-31
2022-04-04
TRENARY RUSSELL III
CEO and President
A - Grant
Stock Option (Right to Buy)
500K
$0.00
1
$56.39M
2022-03-23
2022-03-24
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
21,878
$0.00
1
$56.39M
2022-03-23
2022-03-24
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
21,878
$0.00
1
$56.39M
2021-12-21
2021-12-23
EVANSON JEFF
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
800K
$0.00
1
$56.39M
2021-12-21
2021-12-23
DAGNON TERRY
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
800K
$0.00
1
$56.39M
2021-12-06
2021-12-06
DAGNON TERRY
Chief Operating Officer
P - Purchase
Common Stock
25,201
$1.00
25,201
1
$56.39M
2021-12-06
2021-12-06
TRENARY RUSSELL III
CEO and President
P - Purchase
Common Stock
25,000
$1.00
25,000
1
$56.39M
2021-12-03
2021-12-06
EVANSON JEFF
Chief Commercial Officer
P - Purchase
Common Stock
35,200
$1.00
35,200
1
$56.39M
2021-12-03
2021-12-03
DAGNON TERRY
Chief Operating Officer
P - Purchase
Common Stock
10,000
$1.00
10,000
1
$56.39M
2021-12-02
2021-12-02
TRENARY RUSSELL III
CEO and President
P - Purchase
Common Stock
10,000
$1.00
10,000
1
$56.39M
2021-10-05
2021-10-07
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
47,335
$0.00
1
$56.39M
2021-10-05
2021-10-07
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
44,753
$0.00
1
$56.39M
2021-07-06
2021-07-08
TRENARY RUSSELL III
CEO and President
A - Grant
Stock Option (Right to Buy)
4.00M
$0.00
1
$56.39M
2021-04-20
2021-04-20
KENYON LAWRENCE
CEO, Pres, CFO, Treas & Secy
P - Purchase
Common Stock
10,000
$2.00
20,000
1
$56.39M
2021-03-24
2021-03-26
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
20,873
$0.00
1
$56.39M
2021-03-24
2021-03-26
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
20,873
$0.00
1
$56.39M
2021-02-23
2021-02-25
DAGNON TERRY
Chief Operating Officer
S - Sale
Common Stock
-15,900
$2.00
-31,800
1
$56.39M
2021-02-23
2021-02-25
EVANSON JEFF
Chief Commercial Officer
S - Sale
Common Stock
-8,554
$2.00
-17,108
1
$56.39M
2021-02-12
2021-02-17
DAGNON TERRY
Chief Operating Officer
S - Sale
Common Stock
-63,700
$3.00
-191K
1
$56.39M
2021-02-12
2021-02-17
EVANSON JEFF
Chief Commercial Officer
S - Sale
Common Stock
-56,973
$3.00
-171K
1
$56.39M
2020-10-05
2020-10-05
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
160K
$1.00
160K
1
$56.39M
2020-10-05
2020-10-05
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
152K
$1.00
152K
1
$56.39M
2020-10-01
2020-10-05
KENYON LAWRENCE
CEO, Pres, CFO, Treas & Secy
A - Grant
Stock Option (Right to Buy)
3.67M
$0.00
1
$56.39M
2020-07-17
2020-07-21
KENYON LAWRENCE
CEO, Pres, CFO, Treas & Secy
A - Grant
Stock Option (Right to Buy)
450K
$0.00
1
$56.39M
2020-07-01
2020-07-06
GANGOLLI JULIAN
A - Grant
Stock Option (Right to Buy)
35,006
$1.00
35,006
1
$56.39M
2020-03-23
2020-03-23
BIOLEXIS PTE LTD.
M - Exercise
Series A-1 Convertible Preferred Stock
-68,112
1
$56.39M
2020-03-19
2020-03-23
BIOLEXIS PTE LTD.
A - Grant
Series A-1 Convertible Preferred Stock
68,112
1
$56.39M
2020-03-19
2020-03-23
BIOLEXIS PTE LTD.
D - Sale to Issuer
Series A-1 Convertible Preferred Stock
-68,112
1
$56.39M
2020-03-19
2020-03-20
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$56.39M
2020-03-19
2020-03-20
KENYON LAWRENCE
CEO, Pres, CFO, Treas & Secy
A - Grant
Stock Option (Right to Buy)
216K
$0.00
1
$56.39M
2020-03-19
2020-03-20
SUKHTIAN FAISAL GHIATH
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$56.39M
2020-01-29
2020-01-29
BIOLEXIS PTE LTD.
M - Exercise
Warrant (Right to Buy)
-4.66M
$1.00
-4.66M
3
$56.39M
2020-01-27
2020-01-29
BIOLEXIS PTE LTD.
D - Sale to Issuer
Warrant (Right to Buy)
-4.66M
$1.00
-4.66M
3
$56.39M
2020-01-02
2020-01-06
HADDADIN YEZAN MUNTHER
A - Grant
Stock Option (Right to Buy)
5,980
$1.00
5,980
1
$56.39M
2019-12-31
2019-12-31
BIOLEXIS PTE LTD.
J - Other
Series A-1 Convertible Preferred Stock
1,661
$0.00
1
$56.39M